Filing Details

Accession Number:
0001209191-21-057515
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-23 20:07:46
Reporting Period:
2021-09-22
Accepted Time:
2021-09-23 20:07:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1699382 Pmv Pharmaceuticals Inc. PMVP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1124164 J Arnold Levine C/O Pmv Pharmaceuticals, Inc.
8 Clarke Drive, Suite 3
Cranbury NJ 08512
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-09-22 3,500 $30.00 409,842 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 27, 2021.